Cologne — AYOXXA Biosystems GmbH, an international biotechnology company, completed a € 9,0m Series B financing round by the end of June 2014. All of the company’s existing investors (High-Tech Gründerfonds, KfW, NRW.BANK, Wellington Partners Venture Capital and private investors) took part, along with new investors b-to-v Partners AG, Creathor Venture and HR Ventures. In […]

PALO ALTO, Calif. and WAYNE, Pa.-— Syapse, creators of the Precision Medicine Data Platform, today announced that it raised $10 million in Series B financing, led by Safeguard Scientifics (NYSE:SFE) with participation from Series A investor, The Social+Capital Partnership. This financing will enable Syapse to extend its lead in helping healthcare providers deploy precision medicine […]

CHELMSFORD, MA –- Spectro Scientific, a leading developer and manufacturer of analytical tools and software for fluid and machine condition monitoring, has earned a Small Business Innovation Research (SBIR) Phase II award totaling $750,000 for its work in reevaluating the Joint Oil Analysis Program (JOAP) that consolidates and coordinates the oil analysis programs of the […]

Hawthorne, CA — BioDiscovery, Inc., maker of Nexus Copy Number software, announced today the award of a Small Business Innovation Research (SBIR) Phase I grant from the National Institute of Health to improve the copy number variation (CNV) data from The Cancer Genome Atlas (TCGA), and has selected Huntsman Cancer Institute (HCI) at the University […]

Brussels – Ghent — Qbic and SOFI invest seed capital in VUB start-up in column chromatography Qbic Arkiv Fund and SOFI each invest 250.000 EUR in the VUB start-up Pharmafluidics NV. The company offers a new generation of high-performance columns for chromatographic, molecular separations. Pharmafluidics will use the invested capital for developing a set of […]

NEW YORK, NY — Enzo Biochem, Inc. (NYSE:ENZ) announced today the company was added to the Russell 2000® and Russell 3000® Indexes following the reconstitution of Russell Investment Group’s family of US indexes after the market closed on June 27, 2014. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style […]

SOUTH EASTON, Mass.– Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”) today announced the engagement of IssuWorks to provide strategic advisory services to the Company’s board of directors and management team. IssuWorks is the first conflict-free, company-aligned investment bank using technology and services to dramatically improve investor targeting, securities marketing, and distribution in public […]

Sphere Fluidics has just secured £1.4 million in a First Close of a new investment round. The latter will finally complete in early September 2014 with more potential funding already in the pipeline. “This is the first tranche of funding that we will use to develop a brand new, single cell analysis instrument called Cyto-Mine. […]